|
Anadis Company Profile & Social Media Wall Press Room - Press Releases | ||
A biotechnology company focused on the use of polyclonal antibodies for the treatment and prevention of major diseases, today announced plans for a clinical study to demonstrate the prevention of gastrointestinal damage. | ||
|
Showing along with this industry - Learn more... |
Latest Articles: |
||
Boost Your Social Network & Crowdfunding Campaigns ![]() | |||||||
![]() |
|||||||
|
PREMIUM Members |
|
|